Biotech 2050 Podcast

44
Science #201

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

More
Recent Episodes
  • Steve Tregay on Leading Mission BioCapital as Managing Partner & Fueling Early-Stage Biotech
    Apr 3, 2025 – 00:41:54
  • Neil F. McFarlane, President & CEO of Zevra Therapeutics, on Leading Rare Disease Innovation
    Mar 26, 2025 – 00:35:35
  • Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth
    Mar 20, 2025 – 00:34:03
  • Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences
    Mar 11, 2025 – 00:26:25
  • Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations
    Mar 6, 2025 – 00:59:19
  • Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact
    Feb 26, 2025 – 00:42:53
  • AI, Biotech, & Venture Capital: Alex Bangash, Founder of Transpose, on Future of Startup Investing
    Feb 20, 2025 – 00:23:49
  • Empowering Neurodivergent Innovators: Chad Belinsky on Impact, Mentorship, and Atypical Path
    Feb 12, 2025 – 00:35:35
  • Biotech Venture Investing with Narayan Chowdhury, Co-Founder of Franklin Park LLC
    Feb 6, 2025 – 00:27:32
  • David Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s Future
    Jan 29, 2025 – 00:58:17
  • Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics
    Nov 20, 2024 – 00:38:57
  • Bharatt Chowrira, CEO & Eric Elenko, CoFounder & President of PureTech on Biotech Growth
    Nov 13, 2024 – 00:44:44
  • Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations
    Nov 6, 2024 – 00:23:45
  • Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs
    Oct 30, 2024 – 00:32:01
  • Revolutionizing Heart Health: Bitterroot Bio’s Bold Vision with CEO Pavan Cheruvu
    Oct 23, 2024 – 00:43:07
  • Inside the Journey of Abcuro: CEO Alex Martin on Leadership, IBM, and the Future of Biotech
    Oct 17, 2024 – 00:36:58
  • Precision Neuroscience Breakthroughs: Abe Ceesay, CEO of Rapport Therapeutics I Future of Biotech
    Oct 11, 2024 – 00:47:12
  • Dr. Dave Bearss, Co-Founder & CEO of Halia, on Pioneering Genetic Discoveries to Defeat Alzheimer’s
    Oct 4, 2024 – 00:35:36
  • Breaking Biotech Barriers: Avidity President & CEO Sarah Boyce on RNA’s Next Frontier
    Sep 19, 2024 – 00:35:08
  • Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity
    Aug 28, 2024 – 00:31:40
  • Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam
    Aug 15, 2024 – 00:24:38
  • From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation
    Aug 6, 2024 – 00:30:51
  • Autoimmune Innovations: Insights from Marshall Fordyce, Founder & CEO, Vera Therapeutics on Biotech
    Aug 1, 2024 – 00:32:50
  • Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx
    Jul 24, 2024 – 00:50:25
  • Biotech Breakthroughs: Jeb Keiper, CEO of Nimbus Therapeutics, Discusses Their Innovative Journey
    Jul 17, 2024 – 00:35:03
  • Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development
    Jul 11, 2024 – 00:36:55
  • Exploring Neuroscience, Psychiatry, & Rare Diseases, Bruce Leuchter, President & CEO, Neurvati
    Jun 13, 2024 – 00:51:22
  • Transformative Oncology Innovations, Ken Keller, President & CEO, Daiichi Sankyo, Inc.
    Jun 6, 2024 – 00:28:18
  • Strategic Leadership and Autoimmune Breakthroughs, Praveen Tipimeni, CEO
    May 23, 2024 – 00:34:03
  • Innovative Approaches to Cancer Therapies, Robert Ang, President and CEO
    May 15, 2024 – 00:30:09
  • Tech-Biotech Convergence, Growth, and Global Lessons, Vik Bajaj, Co-founder and CEO
    May 8, 2024 – 00:31:05
  • Advancing and Revolutionizing Sickle Cell Treatment, Ted Love, Chair and BOD
    May 2, 2024 – 00:27:00
  • Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics
    Apr 3, 2024 – 00:31:57
  • Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics
    Mar 27, 2024 – 00:27:55
  • Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma
    Mar 20, 2024 – 00:50:36
  • The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks
    Mar 13, 2024 – 00:40:37
  • Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis
    Mar 6, 2024 – 00:36:41
  • Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics
    Feb 28, 2024 – 00:23:07
  • Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge
    Feb 21, 2024 – 00:26:45
  • The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion
    Feb 14, 2024 – 00:39:42
  • Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group
    Feb 7, 2024 – 00:46:09
  • Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT
    Jan 31, 2024 – 00:33:34
  • Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics
    Jan 10, 2024 – 00:25:30
  • Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics
    Dec 13, 2023 – 00:26:10
  • A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology
    Dec 6, 2023 – 00:20:12
  • The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology
    Nov 29, 2023 – 00:33:25
  • Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine
    Nov 22, 2023 – 00:40:37
  • Developing medicines for broad populations of cancer patients, Brett Hall, CSO, Immuneering
    Nov 15, 2023 – 00:41:03
  • Harnessing the power of microglia, Ivana Magovčević-Liebisch, President & CEO, Vigil Neuroscience
    Nov 8, 2023 – 00:25:37
  • Revolutionizing eyecare treatment, Bobak Azamian, CEO & Chairman, Tarsus Pharmaceuticals
    Nov 1, 2023 – 00:26:37
Recent Reviews
  • Sae36
    Wonderful Diversity of Leadership
    Bravo! From patient focus, to capital formation, to commercial expertise… these conversations are engaging and meaningful to the bio ecosystem.
  • TR-iumph
    Finally!
    Love where this is going, been looking for a podcast to keep me up on the latest and greatest happenings in biotech.
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.